Showing results (151-160 of 181) with videos related to
Sort By:
Pageof 19
The European Respiratory Journal|October 24, 2015
Incident and prevalent cohorts with pulmonary arterial hypertension: insight from SERAPHINGérald Simonneau, Richard N Channick, Marion Delcroix, et al.JACC. Advances|February 25, 2025
Outcomes in Patients Receiving Treatment for Pulmonary Arterial Hypertension Associated With Repaired Congenital Heart DiseaseRichard A Krasuski, Tobore Tobore, Sean Studer, et al.Chest|September 28, 2016
Macitentan Improves Health-Related Quality of Life for Patients With Pulmonary Arterial Hypertension: Results From the Randomized Controlled SERAPHIN TrialSanjay Mehta, Bhagavatula Kutumba Srinivasa Sastry, Rogério Souza, et al.Journal of Clinical Medicine|April 3, 2021
Prostacyclin Analogues Inhibit Platelet Reactivity, Extracellular Vesicle Release and Thrombus Formation in Patients with Pulmonary Arterial HypertensionAleksandra Gąsecka, Marta Banaszkiewicz, Rienk Nieuwland, et al.Plos One|March 29, 2018
Association between six-minute walk distance and long-term outcomes in patients with pulmonary arterial hypertension: Data from the randomized SERAPHIN trialRogério Souza, Richard N Channick, Marion Delcroix, et al.JACC. Heart Failure|December 3, 2014
Effect of macitentan on hospitalizations: results from the SERAPHIN trialRichard N Channick, Marion Delcroix, Hossein-Ardeschir Ghofrani, et al.Thrombosis and Haemostasis|August 14, 2018
Apixaban versus Dalteparin for the Treatment of Acute Venous Thromboembolism in Patients with Cancer: The Caravaggio StudyGiancarlo Agnelli, Cecilia Becattini, Rupert Bauersachs, et al.Journal of the American College of Cardiology|June 27, 2009
Diagnosis, assessment, and treatment of non-pulmonary arterial hypertension pulmonary hypertensionMarius M Hoeper, Joan Albert Barberà, Richard N Channick, et al.Journal of Clinical Medicine|July 9, 2022
Characteristics and Outcomes of Patients Consulted by a Multidisciplinary Pulmonary Embolism Response Team: 5-Year ExperienceArkadiusz Pietrasik, Aleksandra Gąsecka, Paweł Kurzyna, et al.Journal of the American College of Cardiology|April 23, 2003
Effects of the oral endothelin-receptor antagonist bosentan on echocardiographic and doppler measures in patients with pulmonary arterial hypertensionNazzareno Galiè, Alan L Hinderliter, Adam Torbicki, et al.Pageof 19